In the 5xFAD AD model, the absence of Nrf2 leads to reactive astrocyte activation, while enhancing Nrf2 expression impedes NF-κB p65 recruitment to neurotoxic astrocyte genes, reducing their expression. This evidence concerns the gene NFE2L2 and Alzheimer disease.